Preparation method of 3-(2-chloro-pyrimidine-4-yl)-1-methylindole

A technology of methyl indole and chloropyrimidine, which is applied in the field of medicine, can solve the problems of high pollution after treatment and dangerous reaction, and achieve the effect of high yield, safety and easy cost

Inactive Publication Date: 2017-05-17
山东轩德医药科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In the current prior art, such as WO2013 / 14448 A1, 2013, CN105237515 A, 2016, the preparation method of Osimertinib Mesylate and its intermediates is introduced, but the preparation method needs to use highly toxic substances such as methyl iodide, and the reaction is dangerous and Post-processing pollution is large

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of 3-(2-chloro-pyrimidine-4-yl)-1-methylindole

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: Preparation of 3-(2-chloropyrimidin-4-yl)-1-methylindole

[0023]

[0024] With 1.5L methanol, 3-(2-chloropyrimidin-4-yl)-1H-indole (229g), formaldehyde (90g), 10% palladium carbon (20g) was added in the reaction kettle, under hydrogen atmosphere (0.2MPa) , stirred at room temperature for 3 hours, the reaction was completed, filtered, the organic phase was evaporated to dryness, and recrystallized with acetonitrile to obtain the product 3-(2-chloropyrimidin-4-yl)-1-methylindole, 210g, yield: 86.4 %.

[0025] 1H NMR (400MHz, 25℃, DMSO-d6): 3.90(3H,s), 7.30(2H,pd), 7.54-7.60(1H,m), 7.82(1H,d), 8.38-8.44(1H,m ), 8.49(1H,s), 8.53(1H,d).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of 3-(2-chloro-pyrimidine-4-yl)-1-methylindole. According to the method, formaldehyde is adopted as a reaction material, the reaction technology is simple and convenient, the security is high, the yield is high and the mass production can be carried out.

Description

[0001] 1. Technical field [0002] The invention belongs to the technical field of medicine and relates to a method for preparing 3-(2-chloropyrimidin-4-yl)-1-methylindole. [0003] 2. Background technology [0004] Osimertinib (Osimertinib Mesylate, Tagrisso) is a targeted anticancer drug developed by AstraZeneca. It was approved for marketing by the European Medicines Agency (EMA), and then approved for marketing by the Japanese Pharmaceuticals and Medical Devices Administration (PMDA) on March 28, 2016. This drug is used to treat EGFR-T790 mutation-positive non-small cell lung cancer. 3-(2-Chloropyrimidin-4-yl)-1-methylindole is a key intermediate in the synthesis of Osimertinib Mesylate. [0005] In the current prior art, such as WO2013 / 14448 A1, 2013, CN105237515 A, 2016, the preparation method of Osimertinib Mesylate and its intermediates is introduced, but the preparation method needs to use highly toxic substances such as methyl iodide, and the reaction is dangerous a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/04
CPCC07D403/04
Inventor 董岩岩
Owner 山东轩德医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap